Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

Tocilizumab Efficacy in a Patient with Positive Anti-CCP Chronic Lyme Arthritis.

Discussion in 'Lyme Disease and Co-Infections' started by msf, May 24, 2016.

  1. msf

    msf Senior Member

    Messages:
    3,150
    Likes:
    4,340
    http://www.ncbi.nlm.nih.gov/pubmed/27213145

    ´Off label treatment by biologic disease modifying antirheumatic drugs can be considered in selected patients with severe antibiotic-resistant Lyme arthritis.C.´

    I wonder if this could be relevant to ME, and the recent report of anti-CCP antibodies in patients with ME?
     
    Last edited: May 24, 2016

See more popular forum discussions.

Share This Page